CVS HEALTH CORP (1CVS.MI) Fundamental Analysis & Valuation
BIT:1CVS • US1266501006
Current stock price
67.05 EUR
+0.64 (+0.96%)
Last:
This 1CVS.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. 1CVS.MI Profitability Analysis
1.1 Basic Checks
- 1CVS had positive earnings in the past year.
- In the past year 1CVS had a positive cash flow from operations.
- 1CVS had positive earnings in each of the past 5 years.
- Each year in the past 5 years 1CVS had a positive operating cash flow.
1.2 Ratios
- 1CVS has a Return On Assets of 0.70%. This is in the lower half of the industry: 1CVS underperforms 66.67% of its industry peers.
- 1CVS has a Return On Equity of 2.35%. This is in the lower half of the industry: 1CVS underperforms 63.64% of its industry peers.
- With a Return On Invested Capital value of 4.90%, 1CVS perfoms like the industry average, outperforming 42.42% of the companies in the same industry.
- 1CVS had an Average Return On Invested Capital over the past 3 years of 5.46%. This is in line with the industry average of 5.91%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.7% | ||
| ROE | 2.35% | ||
| ROIC | 4.9% |
ROA(3y)1.95%
ROA(5y)2.24%
ROE(3y)6.46%
ROE(5y)7.21%
ROIC(3y)5.46%
ROIC(5y)6.31%
1.3 Margins
- With a Profit Margin value of 0.44%, 1CVS is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
- In the last couple of years the Profit Margin of 1CVS has declined.
- 1CVS has a Operating Margin of 2.58%. This is in the lower half of the industry: 1CVS underperforms 75.76% of its industry peers.
- 1CVS's Operating Margin has declined in the last couple of years.
- 1CVS has a Gross Margin of 13.77%. This is in the lower half of the industry: 1CVS underperforms 63.64% of its industry peers.
- 1CVS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.58% | ||
| PM (TTM) | 0.44% | ||
| GM | 13.77% |
OM growth 3Y-19.74%
OM growth 5Y-12.87%
PM growth 3Y-30.97%
PM growth 5Y-30.29%
GM growth 3Y-6.6%
GM growth 5Y-5.48%
2. 1CVS.MI Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1CVS is destroying value.
- Compared to 1 year ago, 1CVS has more shares outstanding
- 1CVS has less shares outstanding than it did 5 years ago.
- The debt/assets ratio for 1CVS has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 2.32 indicates that 1CVS is not a great score, but indicates only limited risk for bankruptcy at the moment.
- 1CVS has a better Altman-Z score (2.32) than 69.70% of its industry peers.
- The Debt to FCF ratio of 1CVS is 8.27, which is on the high side as it means it would take 1CVS, 8.27 years of fcf income to pay off all of its debts.
- 1CVS has a Debt to FCF ratio (8.27) which is comparable to the rest of the industry.
- A Debt/Equity ratio of 0.80 indicates that 1CVS is somewhat dependend on debt financing.
- With a Debt to Equity ratio value of 0.80, 1CVS perfoms like the industry average, outperforming 57.58% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.8 | ||
| Debt/FCF | 8.27 | ||
| Altman-Z | 2.32 |
ROIC/WACC0.63
WACC7.75%
2.3 Liquidity
- A Current Ratio of 0.84 indicates that 1CVS may have some problems paying its short term obligations.
- 1CVS's Current ratio of 0.84 is on the low side compared to the rest of the industry. 1CVS is outperformed by 63.64% of its industry peers.
- A Quick Ratio of 0.63 indicates that 1CVS may have some problems paying its short term obligations.
- 1CVS has a Quick ratio of 0.63. This is in the lower half of the industry: 1CVS underperforms 63.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.84 | ||
| Quick Ratio | 0.63 |
3. 1CVS.MI Growth Analysis
3.1 Past
- 1CVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.54%, which is quite impressive.
- Measured over the past years, 1CVS shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.11% on average per year.
- 1CVS shows a small growth in Revenue. In the last year, the Revenue has grown by 7.85%.
- Measured over the past years, 1CVS shows a quite strong growth in Revenue. The Revenue has been growing by 8.39% on average per year.
EPS 1Y (TTM)24.54%
EPS 3Y-8.11%
EPS 5Y-2.11%
EPS Q2Q%-8.4%
Revenue 1Y (TTM)7.85%
Revenue growth 3Y7.63%
Revenue growth 5Y8.39%
Sales Q2Q%8.17%
3.2 Future
- The Earnings Per Share is expected to grow by 10.88% on average over the next years. This is quite good.
- The Revenue is expected to grow by 4.08% on average over the next years.
EPS Next Y7.45%
EPS Next 2Y10.69%
EPS Next 3Y12.48%
EPS Next 5Y10.88%
Revenue Next Year1.39%
Revenue Next 2Y2.92%
Revenue Next 3Y3.5%
Revenue Next 5Y4.08%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. 1CVS.MI Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 11.48, which indicates a very decent valuation of 1CVS.
- Based on the Price/Earnings ratio, 1CVS is valued cheaper than 84.85% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 24.88, 1CVS is valued rather cheaply.
- A Price/Forward Earnings ratio of 10.68 indicates a reasonable valuation of 1CVS.
- 1CVS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. 1CVS is cheaper than 78.79% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of 1CVS to the average of the S&P500 Index (22.19), we can say 1CVS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.48 | ||
| Fwd PE | 10.68 |
4.2 Price Multiples
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1CVS is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.63 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- 1CVS's earnings are expected to grow with 12.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.54
PEG (5Y)N/A
EPS Next 2Y10.69%
EPS Next 3Y12.48%
5. 1CVS.MI Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 3.70%, 1CVS has a reasonable but not impressive dividend return.
- Compared to an average industry Dividend Yield of 1.94, 1CVS pays a better dividend. On top of this 1CVS pays more dividend than 93.94% of the companies listed in the same industry.
- 1CVS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.7% |
5.2 History
- The dividend of 1CVS has a limited annual growth rate of 5.96%.
Dividend Growth(5Y)5.96%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
- 1CVS pays out 192.14% of its income as dividend. This is not a sustainable payout ratio.
- The dividend of 1CVS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP192.14%
EPS Next 2Y10.69%
EPS Next 3Y12.48%
1CVS.MI Fundamentals: All Metrics, Ratios and Statistics
BIT:1CVS (3/13/2026, 7:00:00 PM)
67.05
+0.64 (+0.96%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-10 2026-02-10/bmo
Earnings (Next)04-29 2026-04-29/bmo
Inst Owners90.76%
Inst Owner ChangeN/A
Ins Owners0.98%
Ins Owner ChangeN/A
Market Cap85.30B
Revenue(TTM)402.07B
Net Income(TTM)1.77B
Analysts79.39
Price Target81.48 (21.52%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.7% |
Yearly Dividend2.32
Dividend Growth(5Y)5.96%
DP192.14%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.24%
Min EPS beat(2)8.8%
Max EPS beat(2)15.69%
EPS beat(4)4
Avg EPS beat(4)19.56%
Min EPS beat(4)8.8%
Max EPS beat(4)30.76%
EPS beat(8)6
Avg EPS beat(8)7.29%
EPS beat(12)10
Avg EPS beat(12)6.2%
EPS beat(16)14
Avg EPS beat(16)5.76%
Revenue beat(2)2
Avg Revenue beat(2)2.03%
Min Revenue beat(2)1.02%
Max Revenue beat(2)3.04%
Revenue beat(4)4
Avg Revenue beat(4)1.93%
Min Revenue beat(4)0.02%
Max Revenue beat(4)3.64%
Revenue beat(8)5
Avg Revenue beat(8)0.75%
Revenue beat(12)9
Avg Revenue beat(12)1.31%
Revenue beat(16)13
Avg Revenue beat(16)2.17%
PT rev (1m)1.96%
PT rev (3m)5.32%
EPS NQ rev (1m)0.35%
EPS NQ rev (3m)-0.37%
EPS NY rev (1m)0.16%
EPS NY rev (3m)0.47%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)-1.71%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)-3.21%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.48 | ||
| Fwd PE | 10.68 | ||
| P/S | 0.25 | ||
| P/FCF | 12.63 | ||
| P/OCF | 9.26 | ||
| P/B | 1.31 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)5.84
EY8.71%
EPS(NY)6.28
Fwd EY9.36%
FCF(TTM)5.31
FCFY7.92%
OCF(TTM)7.24
OCFY10.79%
SpS273.51
BVpS51.16
TBVpS-24.33
PEG (NY)1.54
PEG (5Y)N/A
Graham Number81.99
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.7% | ||
| ROE | 2.35% | ||
| ROCE | 6.3% | ||
| ROIC | 4.9% | ||
| ROICexc | 5.23% | ||
| ROICexgc | 18.66% | ||
| OM | 2.58% | ||
| PM (TTM) | 0.44% | ||
| GM | 13.77% | ||
| FCFM | 1.94% |
ROA(3y)1.95%
ROA(5y)2.24%
ROE(3y)6.46%
ROE(5y)7.21%
ROIC(3y)5.46%
ROIC(5y)6.31%
ROICexc(3y)5.85%
ROICexc(5y)6.83%
ROICexgc(3y)22.7%
ROICexgc(5y)25.24%
ROCE(3y)7.06%
ROCE(5y)8.13%
ROICexgc growth 3Y-15.72%
ROICexgc growth 5Y-3.91%
ROICexc growth 3Y-15.74%
ROICexc growth 5Y-5.12%
OM growth 3Y-19.74%
OM growth 5Y-12.87%
PM growth 3Y-30.97%
PM growth 5Y-30.29%
GM growth 3Y-6.6%
GM growth 5Y-5.48%
F-Score6
Asset Turnover1.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.8 | ||
| Debt/FCF | 8.27 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 0.7% | ||
| Interest Coverage | -3.47 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 441.57% | ||
| Current Ratio | 0.84 | ||
| Quick Ratio | 0.63 | ||
| Altman-Z | 2.32 |
F-Score6
WACC7.75%
ROIC/WACC0.63
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.77%
Cap/Sales(5y)0.8%
Profit Quality(3y)234.42%
Profit Quality(5y)242.41%
High Growth Momentum
Growth
EPS 1Y (TTM)24.54%
EPS 3Y-8.11%
EPS 5Y-2.11%
EPS Q2Q%-8.4%
EPS Next Y7.45%
EPS Next 2Y10.69%
EPS Next 3Y12.48%
EPS Next 5Y10.88%
Revenue 1Y (TTM)7.85%
Revenue growth 3Y7.63%
Revenue growth 5Y8.39%
Sales Q2Q%8.17%
Revenue Next Year1.39%
Revenue Next 2Y2.92%
Revenue Next 3Y3.5%
Revenue Next 5Y4.08%
EBIT growth 1Y6.02%
EBIT growth 3Y-13.61%
EBIT growth 5Y-5.55%
EBIT Next Year24.52%
EBIT Next 3Y15.26%
EBIT Next 5YN/A
FCF growth 1Y23.41%
FCF growth 3Y-16.58%
FCF growth 5Y-10.28%
OCF growth 1Y16.82%
OCF growth 3Y-13.04%
OCF growth 5Y-7.68%
CVS HEALTH CORP / 1CVS.MI Fundamental Analysis FAQ
What is the fundamental rating for 1CVS stock?
ChartMill assigns a fundamental rating of 4 / 10 to 1CVS.MI.
What is the valuation status of CVS HEALTH CORP (1CVS.MI) stock?
ChartMill assigns a valuation rating of 5 / 10 to CVS HEALTH CORP (1CVS.MI). This can be considered as Fairly Valued.
Can you provide the profitability details for CVS HEALTH CORP?
CVS HEALTH CORP (1CVS.MI) has a profitability rating of 2 / 10.
How financially healthy is CVS HEALTH CORP?
The financial health rating of CVS HEALTH CORP (1CVS.MI) is 3 / 10.
Is the dividend of CVS HEALTH CORP sustainable?
The dividend rating of CVS HEALTH CORP (1CVS.MI) is 6 / 10 and the dividend payout ratio is 192.14%.